Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05754801

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer: A Randomized, Double-blinded, Placebo-controlled Trial

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
172 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
21 Years – 89 Years
Healthy volunteers
Not accepted

Summary

A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine 'Coriolus Versicolor for improving the quality of life of patients with advanced-stage cancer. Subjects will be randomized into a treatment group or placebo group for 6 months.

Detailed description

According to the Compendium of Materia Medica, a classic encyclopedia for Chinese medicines written by the venerated Physician Li ShiZhen of the Ming dynasty, Yunzhi (Coriolus Versicolor) is treasured as a superbly valuable herb as it not only can strengthen and consolidate the body's resistance, as well as reinforce and nourish a person's marrow and kidney essence and also is harmless to patients. Recent research found that the extract from Yunzhi, named as polysaccharide-peptide (PSP), could inhibit the growth of human hematoma cell line \& sarcoma and was proved to have direct anti-cancer effects. Quality of life (QOL) of patients is the ultimate goal of palliative care as endorsed by the World Health Organization (WHO) in 1990. When survival is limited in advanced incurable diseases, quality of life is most important. Patients with advanced cancer (palliative) often manifest numerous physical and psychological symptoms and a poor quality of life. While maintenance of the quality of life of advanced cancer patients is important, the physical dimension of quality of life still needs improvement, especially in the palliative stage. To date, there is no specific supportive Traditional Chinese Medicine(TCM)-related products that have been proven in randomized controlled trials for alleviating these debilitating symptoms and improving their quality of life. The present study aims to scientifically evaluate whether a Yunzhi product named G.E. Yunzhi-Essence is effective and safe in improving the QOL of palliative patients with advanced cancer.

Conditions

Interventions

TypeNameDescription
DRUGYunzhi EssenceYunzhi Essence capsule
OTHERPlaceboPlacebo capsules

Timeline

Start date
2023-04-01
Primary completion
2026-03-31
Completion
2026-09-30
First posted
2023-03-06
Last updated
2023-03-09

Source: ClinicalTrials.gov record NCT05754801. Inclusion in this directory is not an endorsement.